This groundbreaking single strain probiotic is discovered by European researchers, is specifically formulated in Australia for pregnancy and breastfeeding mothers. Containing the patented strain of probiotic Lactobacillus Fermentum CECT5716, originally found in healthy breast milk, Qiara Pregnancy and Breastfeeding has been shown to:
-
maintain a healthy microflora, important for you and baby before, during and after pregnancy
-
restore balance of good bacteria in breast milk that may have been reduced by antibiotics, or other external factors
-
relieve or reduce breast pain and discomfort associated with mild mastitis while breastfeeding
-
reduce the recurrence of mild mastitis
-
Improve general digestive and gut health
Mastitis
According to WHO up to 95% of mastitis is caused by Staph Aureus. Clinical trials have proven Qiara to be effective in helping to inhibit Staph, Strep including Staph Aureus (golden Staph). Overgrowth of Staph can be exacerbated after the use of antibiotics. Recurrent mastitis often leads to early cessation of breastfeeding.
Birth by LSCS (Caesarean)
A study of 627,600 Australian births reported that women who gave birth by C-Section were 70% more likely to be diagnosed with a complication affecting breastfeeding and their babies are at higher risk of infection.
Depending where you birth LSCS mums are routinely administered antibiotics to prevent infection. While necessary, antibiotics are not selective and can also reduce the levels of beneficial and protective flora in the breast milk. This can lead to an imbalance between the ‘good’ and ‘bad’ bacteria and a condition called Dysbiosis.
Breast milk dysbiosis can lead to an increased risk of infections such as mastitis and can also impact the colonisation of the infant’s microbiome and consequent development of their immune system which may affect the health and immunity of the child for life.
Taking Qiara daily before and after your C-section may assist in maintaining the balance of good bacteria in breast milk.
